OpenEvidence vs Xaira Therapeutics
Which Healthcare AI tool is better in 2026?
OpenEvidence
AI medical assistant for clinicians
Xaira Therapeutics
Pioneering transformative artificial intelligence to discover and develop the next generation of life-changing medicines.
Side-by-side
| OpenEvidence | Xaira Therapeutics | |
|---|---|---|
| Tagline | AI medical assistant for clinicians | Pioneering transformative artificial intelligence to discover and develop the next generation of life-changing medicines. |
| Founded | 2022 | — |
| HQ | San Francisco, US | — |
| Employees | 50-200 | — |
| Total funding | $735M | Undisclosed |
| Latest round | Series D · Jan 2026 | — |
| Valuation | $12B | — |
| Cheapest paid plan | — | — |
| Free plan | ✓ Free for Verified US Physicians | ✗ |
| Free trial | ✗ | ✗ |
| Top tier price | — | Enterprise Solutions · Contact sales |
| Pricing summary | 1 published plans | 1 published plans |
| Categories |
Capability matrix
Developer-facing capabilities and access signals for OpenEvidence and Xaira Therapeutics.
| Capability | OpenEvidence | Xaira Therapeutics |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✓ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | 2 (TypeScript, Python) | — |
| Free plan | ✓ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✓ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of OpenEvidence
- Has raised more capital ($735M vs Undisclosed)
- Higher Neuron score (60 vs 12)
- Offers a free plan
- Newer company (2022)
🔵 Strengths of Xaira Therapeutics
- Strong in AI Healthcare
Which should you choose?
Choose Xaira Therapeutics if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose OpenEvidence if you want the most established option — it has raised $735M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
OpenEvidence vs Xaira Therapeutics — which is better?
It depends on your priority. OpenEvidence has raised more capital and is the more established option; Xaira Therapeutics has broader feature depth. See the side-by-side table above.
Is OpenEvidence cheaper than Xaira Therapeutics?
No — Xaira Therapeutics's cheapest paid plan is Enterprise · Contact sales, while OpenEvidence's is Free.
Do OpenEvidence and Xaira Therapeutics offer free plans?
OpenEvidence: Yes, has a free plan. Xaira Therapeutics: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.